Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 124
Genomics 98
Drug Discovery 70
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 58
Cardiovascular Drugs 56
Pharmaceuticals 53
Biopharmaceuticals 42
Biotechnology 39
Leukemia Drugs 35
Clinical Trials 33
Lymphoma Drugs 30
HIV/AIDS Drugs 27
Respiratory Drugs 26
Musculoskeletal Disorders Drugs 26
Enzymes 22
Oncology 22
Pulmonary Medicine 21
Allergy and Immunology 21
Pharmaceutical Manufacturing 21
Drug Delivery 19
Central Nervous System Drugs 17
Infusions and Injectables 17
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 12
Diagnostics 11
Hematological Drugs 11
Endocrine and Metabolic Disorders Drugs 10
Sexual and Reproductive Health Drugs 10
Healthcare Services 9
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Lung Cancer Drugs 6
Stem Cells 6
Nanomedicine 6
Pediatrics 6
Company Reports 5
Colon Cancer Drugs 5
Needles and Syringes 5
Liver Cancer Drugs 4
Generic Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Analgesics 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Pharmacoeconomics 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Anesthetic Drugs 3
Medical Devices 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
E-Healthcare 2
Prostate Cancer Drugs 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Home Testing and Home Healthcare 2
In Vitro Diagnostics 2
Blood Banking 2
Over the Counter (OTC) Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Urological Disorders Drugs 2
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Cardiology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

1,022 Results (Page 24 of 52)
- Relevance
  Sort by

Myelodysplastic Syndrome - Pipeline Review, H1 2020

 Drug Pipelines
June 2020
1667 Pages
Global

From

€1782EUR$2,000USD£1,546GBP

Cell Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and Geography

 Report
December 2024
678 Pages
Global

From

€4276EUR$4,799USD£3,710GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Addictions Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Lung Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Nanomedicine Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
90 Pages
Global

From

€1782EUR$2,000USD£1,546GBP

Small Cell Lung Cancer Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Precision and Personalized Medicine in Pharma - Thematic Intelligence

 Report
June 2023
62 Pages
Global

From

€1738EUR$1,950USD£1,507GBP

Therapeutics for Women's Health: Technologies and Global Markets

 Report
March 2025
159 Pages
Global

From

€4144EUR$4,650USD£3,595GBP

Nanomedicine Market - Forecasts from 2023 to 2028

 Report
September 2023
146 Pages
Global

From

€3172EUR$3,560USD£2,752GBP

€3965EUR$4,450USD£3,440GBP

Liposome Development and Liposome Manufacturing Services Market, 2022-2035: Distribution by Type of Product Formulation, Scale of Operation, End User Industry, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
December 2022
226 Pages
Global

From

€4276EUR$4,799USD£3,710GBP

Basal Cell Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Global TROP2 Antibody Market Opportunity & Clinical Trials Insight 2030

 Report
February 2025
200 Pages
Global

From

€2495EUR$2,800USD£2,165GBP

Melanoma Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Alcohol Use Disorder - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1782EUR$2,000USD£1,546GBP

Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Forecast 2024-2030

 Report
March 2024
180 Pages
Global

From

€3159EUR$3,545USD£2,741GBP

€3510EUR$3,939USD£3,045GBP

Mantle Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

Non Hodgkin Lymphoma (NHL) Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4001EUR$4,490USD£3,471GBP

1,022 Results (Page 24 of 52)
- 1
- 22
- 23
- 24
- 25
- 26

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.